Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.

Alberts, S R; Townley, P M; Goldberg, R M; Cha, S S; Sargent, D J; Moore, D F; Krook, J E; Pitot, H C; Fitch, T R; Wiesenfeld, M; Mailliard, J A

Alberts, S R; Townley, P M; Goldberg, R M; Cha, S S; Sargent, D J; Moore, D F; Krook, J E; Pitot, H C; Fitch, T R; Wiesenfeld, M; Mailliard, J A.

Affiliation

Alberts SR; Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA. alberts.steven@mayo.edu

Ann Oncol ; 14(4): 580-5, 2003 Apr.

Article in En | MEDLINE | ID: mdl-12649105

Subject(s)

Adenocarcinoma/drug therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Deoxycytidine/analogs & derivatives; Pancreatic Neoplasms/drug therapy; Adenocarcinoma/pathology; Adult; Aged; Deoxycytidine/administration & dosage; Disease Progression; Female; Hemolytic-Uremic Syndrome/chemically induced; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds/administration & dosage; Oxaliplatin; Pancreatic Neoplasms/pathology; Survival; Treatment Outcome; Gemcitabine

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Deoxycytidine Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2003 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links